Minimally-invasive and non-invasive continuous glucose monitoring systems: Indications, advantages, limitations and clinical aspects

Current Diabetes Reviews

Volumn 4, Issue 3, 2008, Pages 159-168

  De Block, Christophe ^a,b   Vertommen, Jan ^b   Manuel y Keenoy, Begoña ^b   Van Gaal, Luc ^a,b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Continuous glucose monitoring; Diabetes

Indexed keywords

GLUCOSE; INSULIN; METFORMIN;

ACCURACY; BLOOD GLUCOSE MONITORING; CHRONIC DISEASE; CLINICAL TRIAL; CRITICAL ILLNESS; DEVICE; DIABETES MELLITUS; DRUG DOSE TITRATION; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INVASIVE PROCEDURE; METABOLIC REGULATION; NON INVASIVE PROCEDURE; PREDICTION; PREGNANT WOMAN; PRIORITY JOURNAL; QUALITY OF LIFE; RELIABILITY; REVIEW; SENSOR; STOMACH PARESIS;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; MONITORING, AMBULATORY; MONITORING, PHYSIOLOGIC; PREGNANCY; PREGNANCY COMPLICATIONS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 54749111511     PISSN: 15733998     EISSN: None     Source Type: Journal    
DOI: 10.2174/157339908785294415     Document Type: Review

References (79)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonyltureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 854-865.
3. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group: Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-53.
4. Schütt M, Kern W, Krause U, et al. DPV Initiative. Is the frequency of self-monitoring of blood glucose related to long-term-metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006; 114: 384-388.
5. Koschinsky T, Heinemann L. Sensors for glucose monitoring: technical and clinical aspects. Diabetes Metab Res Rev 2001; 17: 113-123.
6. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care 2005; 28: 1231-1239.
7. Bode B, Gross K, Rikalo N, et al. Alarms based on real-time sensor glucose values alert patients to hypo- and hyperglycaemia: the Guardian continuous monitoring system. Diabetes Technol Ther 2004; 6: 105-113.
8. Sparacino G, Zanderigo F, Corazza S, Maran A, Facchinetti A, Cobelli C. Glucose concentration can be predicted ahead in time from continuous glucose monitoring sensor time-series. IEEE Trans Biomed Eng 2007; 54: 931-937.
9. Kaufman FR, Gibson LC, Halvorson M, Carpenter S, Fisher LK, Pitukcheewanont P. A pilot study of the continuous glucose monitoring system: clinical decisions and glycaemic control after its use in pediatric type 1 diabetic subjects. Diabetes Care 2001; 24: 2030-34.
10. Schaepelynck-Bélicar P, Vague P, Simonin G, Lassmann-Vague V. Improved metabolic control in diabetes adolescents using the continuous glucose monitoring system (CGMS). Diabete Metab 2003; 29: 608-612.
11. Halvorson M, Carpenter S, Kaiserman K, Kaufman FR. A pilot trial in pediatrics with the sensor-augmented pump: combining real-time glucose monitoring with the insulin pump. J Pediatr 2007; 150: 103-105.
12. The Diabetes Research in. Children Network (DirecNet) Study Group. Continuous glucose monitoring in children with type 1 diabetes. J Pediatr 2007; 151: 388-393.
13. Kruger D, Marcus AO. Psychological motivation and patient education: a role for continuous glucose monitoring. Diabetes Technol Ther 2000; 2: S93-S97.
14. The Diabetes Research in Children Network (DirecNet) Study Group. Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes. Diabetes Care 2005; 28: 1929-1935.
15. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999; 46: 183-190.
16. Salardi S, Zucchini S, Santoni R, et al. The glucose area under the profiles obtained with continuous glucose monitoring system relationship with HbA(1c) in pediatric type 1 diabetic patients. Diabetes Care 2002; 25: 1840-1844.
17. Schiaffini R, Ciampalini P, Fierabracci A, et al. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycaemic risk. Diabetes Metab Res Rev 2002; 18: 324-329.
18. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004; 27: 734-738.
19. Garg S, Jovanovic L. Relationship of fasting and hourly blood glucose levels to HbA1c values: Safety, accuracy, and improvements in glucose profiles obtained using a 7-day continuous glucose sensor. Diabetes Care 2006; 29: 2644-2649.
20. Garg SK, Kelly WC, Voelmle MK, et al. Continuous home monitoring of glucose: improved control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007; 30: 3023-3025.
21. Bailey TS, Zisser HC, Garg SK. Reduction in hemoglobin A1c with real-time continuous glucose monitoring: Results from a 12-week observational study. Diabetes Technol Ther 2007; 9: 203-210.
22. Chase HP, Kim LM, Owen SL, et al. Continuous subcutaneous glucose monitoring in children with type 1 diabetes. Pediatrics 2001; 107: 222-226.
23. Chase HP, Roberts MD, Wightman C, et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003; 111: 790-794.
24. Chico A, Vidal-Rios P, Subira MN, Novials A. The continuous glucose monitoring system is useful for detecting unrecognized hypoglycaemias in patients with type 1 and type 2 diabetes but is not better than frequent capillary glucose measurements for improving metabolic contro. Diabetes Care 2003; 26: 1153-1157.
25. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003; 111: 933-938.
26. Tanenberg R, Bode B, Lane W, et al. Use of the Continuous Glucose Monitoring System to guide therapy in patients with insulin-treated diabetes: A randomized controlled trial. Mayo Clin Proc 2004; 79: 1521-1526.
27. The Diabetes Research in Children Network (DirecNet) Study Group. A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005; 28: 1101-1106.
28. The Diabetes Research in Children Network (DirecNet) Study Group. Eight-point glucose testing versus the continuous glucose monitoring system in evaluation of glycaemic control in type 1 diabetes. J Clin Endocrinol Metab 2005; 90: 3387-3391.
29. Lagarde WH, Barrows FP, Davenport ML, Kang M, Guess HA, Calikoglu AS. Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatric Diabetes 2006; 7: 159-164.
30. Garg S, Zisser H, Schwartz S, et al. Improvement in glycaemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006; 29: 44-50.
31. Deiss D, Bolinder J, Riveline JP, et al. Improved glycaemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitioring. Diabetes Care 2006; 29: 2730-2732.
32. Deiss D, Hartmann R, Schmidt J, Kordonouri O. Results of a randomized controlled cross-over trial on the effect of continuous subcutaneous glucose monitoring (CGMS) on glycaemic control in children and adolescents with type 1 diabetes. Exp Clin Endocrinol Diabetes 2006; 114: 63-67.
33. Yates K, Milton AH, Dear K, Ambler G. Continuous glucose monitoring-guided insulin adjustments in children and adolescents on near-physiological insulin regimens. Diabetes Care 2006; 29: 1512-1517.
34. Lee SW, Sweeney T, Clausen D, et al. Combined insulin pump therapy with real-time continuous glucose monitoring significantly improves glycaemic control compared to multiple daily injection therapy in pump naïve patients with type 1 diabetes; single center pilot study experience. J Diabetes Sci Technol 2007; 1: 400-404.
35. Tamborlane W, Ruedy K, Wysocki T, et al. JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: Research design and methods. Diabetes Technol Ther 2008; 10 (in press).
36. Bode BW, Schwartz S, Stubbs HA, Block JE. Glycaemic characteristics in continuously monitored patients with type 1 and type 2 diabetes: normative values. Diabetes Care 2005; 28: 2361-2366.
37. Wentholt IME, Maran A, Masurel N, Heine RJ, Hoekstra JBL, DeVries JH. Nocturnal hypoglycaemia in type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med 2007; 24: 527-532.
38. Amin R, Ross K, Acerini CL, Edge JA, Warner J, Dunger DB. Hypoglycaemia prevalence in prepubertal children with type 1 diabetes on standard insulin regimen: use of continuous glucose monitoring system. Diabetes Care 2003; 26: 662-667.
39. Weintrob N, Schechter A, Benzaquen H, et al. Glycaemic patterns detected by continuous subcutaneous glucose sensing in children and adolescents with type 1 diabetes mellitus treated by multiple dally injections vs continuous subcutaneous insulin infusion. Arch Pediatr Adolesc Med 2004; 158: 677-684.
40. Kubiak T, Hermanns N, Schreckling H, Kulzer B, Haak T. Assessment of hypoglycaemia awareness using continuous glucose monitoring. Diabet Med 2004; 21:487-490.
41. Boland E, Monsod T, Delucia M, Brandt CA, Fernando S, Tamborlane WV. Limitations of conventional methods of self-monitoring of blood glucose: lessons learned from 3 days of continuous glucose sensing in pediatric patients with type 1 diabetes. Diabetes Care 2001; 24: 1858-1862.
42. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA 2006; 295: 1707-1708.
43. Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes, JAMA 2006; 298: 1681-1687.
44. Wentholt IM, Kulik W, Michels RP, Hoekstra JB, deVries JH. Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes. Diabetologia 2008; 51: 183-190.
45. Kovatchev B, Clarke W. Continuous glucose monitoring (CGM) reduces risks for hypo- and hyperglycemia and glucose variability in diabetes. Diabetes 2007; 56 (Suppl 1): A23.
46. Manuel-y-Keenoy B, Vertommen J, Abrams P, et al. Postprandial glucose monitoring in type 1 diabetes mellitus: use of a continuous subcutaneous monitoring device. Diabetes Metab Res Rev 2004; 20 (Suppl.2): S24-S31.
47. De Block CEM, De Leeuw IH, Pelckmans PA, Van Gaal LF. Current concepts in gastric motility in diabetes mellitus. Curr Diabetes Rev 2006; 2: 113-130.
48. Tanenberg RJ, Pfeifer MA. Continuous glucose monitoring system: a new approach to the diagnosis of diabetic gastroparesis. Diabetes Technol Ther 2000; 2 (Suppl.1): S73-S80.
49. Mitka M. Poor patient adherence may undermine the aim of continuous glucose monitoring. JAMA 2007; 298: 614-615.
50. Hirsch IB, Bode BW, Abelseth J, et al. Sensor augmented pump therapy: results of the first treat-to-target study. Diabetes 2007; 56 (Suppl 1): A24.
51. Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycaemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol 2004; 191: 949-953.
52. Kestilä KK, Ekblad UU, Rönnemaa T. Continuous glucose monitoring versus self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract 2007; 77: 174-179.
53. Yogev Y, Ben-Haroush A, Chen R, Kaplan B, Phillip M, Hod M. Continuous glucose monitoring for treatment adjustment in diabetic pregnancies: a pilot study. Diabet Med 2003; 20: 558-562.
54. Chen R, Yogev Y, Ben-Haroush A, Jovanovic L. Hod M, Phillip M. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med 2003; 14: 256-260.
55. Kerssen A, de Valk HW, Visser GH. Day-to-day glucose variability during pregnancy in women with type 1 diabetes mellitus: glucose profiles measured with the continuous glucose monitoring system. Diabet Med 2003; 20: 1012-1015.
56. McLachlan K, Jenkins A, O'Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol 2007; 47: 186-190.
57. Murphy HR, Rayman G, Duffield K, et al. Changes in the glycaemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care 2007; 30: 2785-2791.
58. De Block C, Rogiers P. Glucose control and monitoring at the ICU. In: "Yearbook of Intensive Care and Emergency Medicine 2007". Ed. Vincent JL; Springer-Verlag Heidelberg, Germany 2007; pp. 113-129.
59. De Block CEM, Manuel y Keenoy B, Rogiers P, Van Gaal LF. Intensive insulin therapy in the Intensive Care Unit: Assessment by continuous glucose monitoring. Diabetes Care 2006; 29: 1750-1756.
60. Wilson DM, Block J. Real-time continuous glucose monitor use and patient selection: what have we learned and where are we going? Diabetes Technol Ther 2005; 7: 788-791.
61. Hirsch IB. Algorithms for care in adults using continuous glucose monitoring. J Diabetes Sci Technol 2007; 1: 126-129.
62. Rebrin K, Steil GM, Van Antwerp WP, Mastrototaro JJ. Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol 1999; 277 (Endocrinol Metab 40): E561-E571.
63. Steil GM, Rebrin K, Hariri F, et al. Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia 2005; 48: 1833-1840.
64. Rossetti P, Porcellati F, Fanelli C, Bolli G. Evaluation of the accuracy of a microdialysis-based glucose sensor during insulin-induced hypoglycaemia, its recovery, and post-hypoglycemic hyperglycemia in humans. Diabetes Technol Ther 2006; 8: 326-337.
65. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes 2003; 52: 2790-2794.
66. Aussedat B, Dupire-Angel M, Gifford R, Klein JC, Wilson GS, Reach G. Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab 2000; 278: E716-728.
67. Caplin NJ, O'Leary P, Bulsara M, Davis EA, Jones TW. Subcutaneous glucose sensor values closely parallel blood glucose during insulin-induced hypoglycaemia Diabet Med 2003; 20: 238-241.
68. Rebrin K, Steil GM. Can interstitial glucose assessment replace blood glucose measurements? Diabetes Technol Ther 2000; 2: 461-472.
69. Wentholt IM, Vollebregt MA, Hart AA, Hoekstra JB, deVries JH. Comparison of a needle-type and a microdialysis continuous glucose monitor in type 1 diabetic patients. Diabetes Care 2005; 28: 2871-2876.
70. Diabetes in Research Children Network (DirectNet) Study Group. Evaluation of factors affecting CGMS calibration. Diabetes Technol Ther 2006; 8: 318-325.
71. Feldman B, Brazg R, Schwartz S, Weinstein R. A continuous glucose sensor based on Wired Enzyme™ technology - Results from a 3-day trial in patients with type 1 diabetes. Diabetes Technol Ther 2003; 5: 769-779.
72. Kovatchev BP, Gonder-Frederick LA, Cox DJ, Clarke WL. Evaluating the accuracy of continuous glucose monitoring-sensors. Continuous glucose-error grid analysis illustrated by TheraSense Freestyle Navigator data. Diabetes Care 2004; 27: 1922-1928.
73. Clarke WL, Anderson S, Farhy L, et al. Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 2005; 28: 2412-2417.
74. Poscia A, Mascini M, Luzzana M, et al. A microdialysis technique for continuous subcutaneous glucose monitoring in diabetic patients. Biosens Bioelectron 2003; 18: 891-898.
75. Maran A, Crepaldi C, Tiengo A, et al. Continuous subcutaneous glucose monitoring in diabetic patients: a multicenter trial. Diabetes Care 2002; 25: 347-352.
76. Weinstein RL, Schwartz SL, Brazg RL, Bugler JR, Peyser T, McGarraugh GV. Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: comparison with frequent laboratory reference measurements. Diabetes Care 2007; 30: 1125-1130.
77. Heinemann L. Continuous glucose monitoring: today and tomorrow. Infusyst Int 2004; 3: 9-13.
78. Heinemann L. Noninvasive glucose monitoring systems: will me ever have such sensors for practical use? J Diabetes Sci Technol 2007; 1: 936-939.
79. Wentholt IM, Hoekstra JB, Zwart A, DeVries JH. Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia 2005; 48: 1055-1058.